← back to search

Clemens W.G.M. Löwik

Erasmus MC Cancer Institute · NL
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Bone health and treatments, Nanoplatforms for cancer theranostics, Photodynamic Therapy Research Studies, and Bone Metabolism and Diseases.
h-index
85
citations
25,213
works
404
NIH funding
primary concept
Medicine
email

Recent publications

Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti-PD-1 Shows Response in Murine Immunological T-cell-High and T-cell-Low PDAC Models.
2025cited by 3position: contributordoi
Supplementary Fig. 7 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025cited by 0position: contributordoi
Data from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025cited by 0position: contributordoi
Supplementary Fig. 1 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025cited by 0position: contributordoi
Supplementary Fig. 3 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025cited by 0position: contributordoi
Supplementary Fig. 4 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025cited by 0position: contributordoi
Supplementary Fig. 6 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025cited by 0position: contributordoi
Supplementary Fig. 5 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025cited by 0position: contributordoi
Supplementary Fig. 2 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025cited by 0position: contributordoi
A Novel Luciferase-Based Reporter Gene Technology for Simultaneous Optical and Radionuclide Imaging of Cells.
2024cited by 0position: contributordoi
Indocyanine-enhanced mouse model of bleomycin-induced lung fibrosis with hallmarks of progressive emphysema.
2023cited by 14position: contributordoi
Improved Multimodal Tumor Necrosis Imaging with IRDye800CW-DOTA Conjugated to an Albumin-Binding Domain.
2022cited by 0position: contributordoi
Development of a New Hyaluronic Acid Based Redox-Responsive Nanohydrogel for the Encapsulation of Oncolytic Viruses for Cancer Immunotherapy.
2021cited by 28position: contributordoi
In Vivo Evaluation of Gallium-68-Labeled IRDye800CW as a Necrosis Avid Contrast Agent in Solid Tumors.
2021cited by 5position: contributordoi
Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session
Journal of Controlled Release 2020cited by 74position: middledoi
pH-Channeling in Cancer: How pH-Dependence of Cation Channels Shapes Cancer Pathophysiology.
2020cited by 37position: contributordoi
NanoBiT System and Hydrofurimazine for Optimized Detection of Viral Infection in Mice-A Novel in Vivo Imaging Platform.
2020cited by 15position: contributordoi
EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer
Journal of Controlled Release 2016cited by 167position: middledoi
Degradation, intra-articular retention and biocompatibility of monospheres composed of [PDLLA-PEG-PDLLA]-b-PLLA multi-block copolymers
Acta Biomaterialia 2016cited by 27position: middledoi
Near-infrared labeled, ovalbumin loaded polymeric nanoparticles based on a hydrophilic polyester as model vaccine: In vivo tracking and evaluation of antigen-specific CD8+ T cell immune response
Biomaterials 2014cited by 67position: middledoi
Characterization and Evaluation of the Artemis Camera for Fluorescence-Guided Cancer Surgery
Molecular Imaging and Biology 2014cited by 41position: middledoi
Intraoperative fluorescence delineation of head and neck cancer with a fluorescent Anti‐epidermal growth factor receptor nanobody
International Journal of Cancer 2013cited by 85position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

· 16 papers (2020–2025) · 13 papers (2021–2025)Stefania Farina · Erasmus MC9 papers (2025–2025)Roisin McMorrow · Erasmus MC9 papers (2025–2025)Pier G. Mastroberardino · University of L'Aquila9 papers (2025–2025)Ivo Que · 9 papers (2025–2025)Henriette S. de Bruijn · 9 papers (2025–2025)Dominic J. Robinson · 9 papers (2025–2025)Ruben J.L. van Ardenne · 9 papers (2025–2025)Alexander L. Vahrmeijer · University of Arizona Cancer Center4 papers (2013–2020)Sabrina Oliveira · Utrecht University4 papers (2013–2020)Paul M.P. van Bergen en Henegouwen · Utrecht University3 papers (2013–2020) · 3 papers (2013–2016) · 3 papers (2013–2016)Pieter B. A. A. van Driel · Isala3 papers (2013–2016)Marcus C.M. Stroet · Erasmus MC3 papers (2021–2024)Yann Seimbille · Erasmus MC3 papers (2021–2024)Kranthi M. Panth · Erasmus MC Cancer Institute3 papers (2021–2024)Wim E. Hennink · Utrecht University2 papers (2014–2016)Cornelis J.�H. van de Velde · Leiden University Medical Center2 papers (2014–2016)